Full history for every metric is available with a Kvantra account

Stock profile
IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc. (IDXX)

Country: United States of AmericaSector: HealthcareIndustry: Medical - Diagnostics & ResearchExchange: NASDAQ
P/E TTM
45.6
History
P/E NTM
40.6
Market cap
53.28B
Currency USD
KvantraRankAbout40
IValue13
IIQuality96
IIIMomentum6
Current price
676.21 USD-1.95%
Close 20 Nov 2026
Interval
Benchmarks

Key financial summary

Financials in USD
202020212022202320242025TTM2026E
Total revenue$m2,7073,2153,3673,6613,8984,3044,6624,749
Operating profit$m1,3601,506
Net profit$m5827456798458881,0591,1821,192
EPS reported$13.0814.83
Operating cashflow per share$14.7518.00
Capex per share$1.561.46
FCF per share$13.2016.54
Free cash flow$m1,0571,304
Net debt$m897775
Book value equity$m1,6051,869
Book value per share$19.9023.65
Number of sharesm80.6879.05
DPS (TTM paid)$0.000.00

Financial summary

Financials in USD
202020212022202320242025TTM2026E
Value
P/E TTMx51.7245.60
P/B LTMx33.7528.50
P/S LTMx12.5911.43
P/FCF LTMx51.2640.86
EV/EBITDA LTMx36.5432.33
EV/Sales LTMx12.8011.59
Earnings Yield LTM%1.93%2.19%
FCF Yield%1.95%2.45%
Quality
ROE%65.99%71.18%
ROIC%40.27%39.88%
Operating margin%31.60%32.30%
Gross margin%61.80%62.72%
FCF/Sales%24.56%27.97%
Growth and momentum
EPS Growth YoY%+22.59%+17.61%
Sales Growth YoY%+10.42%+11.87%
Net Income Growth YoY%+19.33%+15.06%
FCF Growth%+32.46%+36.74%
Operating Profit Growth%+20.53%+15.31%
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx0.981.34
Net Debt/EBITDAx0.600.46
EBIT/Net interestx35.5441.96
Net debt/market cap%1.66%1.46%
Net debt/Equityx0.560.41
Gross debt/equityx0.670.52

ETFs that hold IDEXX Laboratories

FundTickerPosition#Weight
Invesco S&P 500 Equal Weight ETFRSP50.26%
Xtrackers S&P 500 Equal Weight UCITS ETF 1CXDEW.L50.26%
iShares S&P 500 Equal Weight UCITS ETF USD (Acc)EWSP.L50.26%
iShares U.S. Medical Devices ETFIHI45.48%
Xtrackers S&P 500 Equal Weight Scored & Screened UCITS ETF 1CXZEW.L50.46%
Invesco Water Resources ETFPHO28.18%
First Trust Water ETFFIW14.74%
Invesco S&P 500 Equal Weight UCITS ETFSPEQ.L40.27%
Invesco S&P 500 Equal Weight Index ETF IncSPED.L40.27%
First Trust Nasdaq-100 Select Equal Weight ETFQQEW22.75%

Funds with IDEXX Laboratories among their ten largest holdings, largest fund first.

Price target estimates

Low estimate
High estimate
Price consensus
Last year average price target
Current price676.21 USD
Return Potential

Based on consensus from external analysts. Not Kvantra's opinion.

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

ESG

Metric202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating

Company overview

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Websiteidexx.com
Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

IDEXX Laboratories, Inc. (IDXX)

IDXX · NASDAQ · Healthcare
676.21 USD-1.95%
Sign up to track this stock
Benchmarks
KvantraRank40
Market cap53.28B
P/E NTM40.6
P/E TTM45.6
KvantraRank?40 / 100
Value
13
Quality
96
Momentum
6
Financialsin USD
20242025TTM2026E
ETFs that hold IDEXX Laboratories
FundTickerPosition#Weight
Invesco S&P 500 Equal Weight ETFRSP50.26%
Xtrackers S&P 500 Equal Weight UCITS ETF 1CXDEW.L50.26%
iShares S&P 500 Equal Weight UCITS ETF USD (Acc)EWSP.L50.26%
iShares U.S. Medical Devices ETFIHI45.48%
Xtrackers S&P 500 Equal Weight Scored & Screened UCITS ETF 1CXZEW.L50.46%
Invesco Water Resources ETFPHO28.18%
First Trust Water ETFFIW14.74%
Invesco S&P 500 Equal Weight UCITS ETFSPEQ.L40.27%
Invesco S&P 500 Equal Weight Index ETF IncSPED.L40.27%
First Trust Nasdaq-100 Select Equal Weight ETFQQEW22.75%

Funds with IDEXX Laboratories among their ten largest holdings, largest fund first.

Analyst target
Consensus
Current676.21 USD
Upside
Price consensus
Last year average price target
Current price676.21 USD
Return Potential

Consensus from external analysts. Not Kvantra's opinion.

Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

ESG
202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating
About

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Websiteidexx.com
IndustryMedical - Diagnostics & Research
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free